Sale!

NSG-552 Exam 3 August 2026

Original price was: $ 50.00.Current price is: $ 30.00.

Order via WhatsApp
Category:

NSG-552 Exam 3 August 2026

NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026
NSG-552 Exam 3 August 2026

Stimulants such as Concerta exert their therapeutic effect by:

  1. A) Blocking NE
  2. B) Decreasing dopamine in the nucleus accumbens
  3. C) Increasing dopamine in the prefrontal cortex
  4. D) Agonism of alpha-2 receptors

A patient presents to you requesting detox. They present with the following symptoms: anxiety, lacrimation, muscle aches, abdominal cramps, and diarrhea. They tell you these symptoms started a day ago and have been worsening since then. Which of the following would be most appropriate to treat this patient’s withdrawal symptoms?

  1. A) Lorazepam IV/PO
  2. B) Buprenorphine/naloxone PO
  3. C) Haloperidol IM/PO
  4. D) Naloxone IV

TY is a 19-year-old male brought into the ER with the following presentation: unconscious, miosis, BP 90/52, HR 48, RR 8, temperature 95oF. Which of the following substances is TY most likely acutely intoxicated with?

  1. A) Alcohol
  2. B) Cocaine
  3. C) Heroin
  4. D) Marijuana

TY is a 19-year-old male brought into the ER with the following presentation: unconscious, miosis, BP 90/52, HR 48, RR 8, temperature 95oF. Which of the following treatments would be the most appropriate medication to treat TY’s acute intoxication?

  1. A) Lorazepam IV
  2. B) Buprenorphine/naloxone PO
  3. C) Supportive care
  4. D) Naloxone IV

Which of the following is a concern if buprenorphine is started too soon after a patient’s last opioid use?

  1. A) Buprenorphine will displace any residual opioids from the μ receptors and can precipitate withdrawal symptoms.
  2. B) Buprenorphine will not be able to bind to μ receptors and may be ineffective in managing withdrawal symptoms.
  3. C) Buprenorphine can have synergistic effects with residual opioids at the μ receptors and cause intoxication.
  4. D) Buprenorphine will not be able to be metabolized and may cause hepatotoxicity.

Which of the following describes the mechanism of action of buprenorphine?

  1. A) NMDA receptor antagonist
  2. B) μ-opioid receptor partial agonist
  3. C) μ-opioid receptor antagonist
  4. D) μ-opioid receptor full agonist…………………………………………………………purchase this entire exam at $30 only

Reviews

There are no reviews yet.

Be the first to review “NSG-552 Exam 3 August 2026”

Your email address will not be published. Required fields are marked *

Shopping Cart